TY - JOUR T1 - Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report. AU - Wong,Noelle Y, AU - Parsons,Laurie M, AU - Trotter,Martin J, AU - Tsang,Roger Y, Y1 - 2014/11/05/ PY - 2014/05/27/received PY - 2014/10/20/accepted PY - 2014/11/6/entrez PY - 2014/11/6/pubmed PY - 2015/6/27/medline SP - 785 EP - 785 JF - BMC research notes JO - BMC Res Notes VL - 7 N2 - BACKGROUND: Drug-induced subacute cutaneous lupus erythematosus is an uncommon disorder associated with the use of pharmacological agents including systemic chemotherapy. CASE PRESENTATION: We report a case of docetaxel-induced subacute cutaneous lupus erythematosus in a 60-year-old Caucasian female with Sjögren's syndrome diagnosed 2 months after receiving docetaxel as part of the adjuvant FEC-D (5-fluorouracil, epirubicin, cyclophosphamide, docetaxel) chemotherapy protocol for early stage breast cancer. Although the exact mechanisms behind the autoimmune response elicited by docetaxel are unclear, the involvement of anti-SSA/Ro antibodies has been implicated. CONCLUSION: This case highlights the symptom severity and clinical course of docetaxel-induced subacute cutaneous lupus erythematosus, and highlights the importance of recognizing this uncommon but potentially severe chemotherapy-associated cutaneous reaction. SN - 1756-0500 UR - https://www.unboundmedicine.com/medline/citation/25369825/Drug_induced_subacute_cutaneous_lupus_erythematosus_associated_with_docetaxel_chemotherapy:_a_case_report_ DB - PRIME DP - Unbound Medicine ER -